Evotec stock heads into the open after a 2.6% TecDAX gain

At the close on September 17, 2026, Evotec stock firmed on Xetra while the TecDAX finished in positive territory. The shares ended the session near their 52-week low after an intraday high around EUR 2.88, leaving the stock only a small margin above recent lows.

Evotec stock closed at EUR 2.88 on Xetra on September 17, 2026, up 2.6% versus the prior session according to TecDAX closing data. The move left the shares only a narrow distance above their 52-week low, highlighting the still cautious sentiment around the name.

September 17, 2026 in numbers

Evotec SE (ISIN DE0005664809) participated in a broadly positive technology trade in Germany on September 17, 2026, with its Xetra closing price reported at EUR 2.88 and a day gain of 2.6%. As the TecDAX ended the session on green ground, Evotec ranked among the stronger constituents with a 2.64% rise to EUR 2.88, per index data cited in a market summary from finanzen.ch. Earlier that day, separate price indications showed the share changing hands around EUR 2.83 on Xetra, roughly 2.33% above a 52-week low of EUR 2.77 reached on September 15, 2026, based on data referenced by ad-hoc-news. With the stock closing above the recent low but still near the bottom of its one-year range, the session underlined how sensitive the shares remain to sector and index swings.

Today’s focus for Evotec

Today, September 18, 2026, Evotec enters the new session without a fresh company-specific release in the early morning, so the share price is primarily exposed to broader moves in German technology equities and the TecDAX after the previous day’s index gains, as reflected in the wrap from finanzen.ch. The recent proximity of Evotec’s share price to its 52-week low, as described by ad-hoc-news, may keep investors attentive to upcoming sector news or macro indicators that could influence risk appetite for smaller biotech stocks in the days ahead.